AVAX Technologies Inc AVXT:Over The Counter Market

Last Price$0.0001Over The Counter Market Previous Close - Last Trade as of 1:58PM ET 12/03/21
Over The Counter Market 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$0.0002 (10,000)
Ask (Size)$0.0027 (10,000)
Day Low / HighN/A - N/A
Volume9.0 K

View Biotechnology IndustryPeer Comparison as of 12/03/2021


AVAX Technologies Inc ( OTC )

Price: $0.0001
Change: 0.00 (0.00%)
Volume: 9.0 K
1:58PM ET 12/03/2021

Pathfinder Cell Therapy Inc ( OTC )

Price: $0.00
Change: 0.00 (0.00%)
Volume: 700.00
12:09PM ET 11/10/2021

Foru Holdings Inc ( OTC )

Price: $0.001
Change: 0.00 (0.00%)
Volume: 987.00
3:20PM ET 11/29/2021

NanoLogix Inc ( OTC )

Price: $0.0002
Change: 0.00 (0.00%)
Volume: 11.1 K
1:23PM ET 12/03/2021

Woodbrook Group Holdings Inc ( OTC )

Price: $0.0014
Change: 0.00 (0.00%)
Volume: 50.00
9:46AM ET 9/21/2021

Read more news Recent News

No news stories available at this time.

View all Commentary and Analysis

No news stories available at this time.

Company Profile

Business DescriptionAVAX Technologies, Inc. is an immuno-oncology company, which engages in the provision of development and commercialization of vaccine therapies and technologies for the treatment of cancer. It offers biological manufacturing services to biotechnology and pharmaceutical companies. The company was founded by Kenneth E. Kovan on January 12, 1990 and is headquartered in Philadelphia, PA.
Address2000 Hamilton Street
Philadelphia, Pennsylvania 19130
Number of Employees29
Chief Executive Officer & DirectorAdele Sommerfeld

Company Highlights

Price Open$0.0001
Previous Close$0.0001
52 Week Range$0.0001 - 0.02
Market Capitalization$14.3 K
Shares Outstanding142.6 M
SectorHealth Technology
Next Earnings AnnouncementN/A

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.05
Beta vs. S&P 500N/A
Revenue$617.4 K
Net Profit Margin-1,004.42%
Return on Equity2,774.88%